英文名稱 | Suzetrigine (Synonyms: VX-548) |
---|---|
中文名稱 | 4-((2R,3S,4S,5R)-3-(3,4-二氟-2-甲氧基苯基)-4,5-二甲基-5-(三氟甲基)四氫呋喃-2-甲酰胺)吡啶-2-甲酰胺 |
CAS號 | 2649467-58-1 |
分子式 | C21H20F5N3O4 |
分子量 | 473.39 |
英文名稱 | Suzetrigine (Synonyms: VX-548) |
---|---|
中文名稱 | 4-((2R,3S,4S,5R)-3-(3,4-二氟-2-甲氧基苯基)-4,5-二甲基-5-(三氟甲基)四氫呋喃-2-甲酰胺)吡啶-2-甲酰胺 |
CAS號 | 2649467-58-1 |
分子式 | C21H20F5N3O4 |
分子量 | 473.39 |
Suzetrigine (VX-548) is a selective NaV1.8 inhibitor with oral bioavailability, acting as a potent analgesic. It targets the sodium channel protein type 10 subunit alpha, playing a key role in pain transmission. This drug candidate shows promise in acute pain management post-abdominoplasty and bunionectomy, presenting as a non-opioid analgesic option.
Gender difference in the pharmacokinetics and metabolism of VX-548 in rats.
PMID: 38573807 DOI: 10.1002/bdd.2387
Biomed Chromatogr. 2024 Jul;38(7):e5907.
Selective Inhibition of NaV1.8 with VX-548 for Acute Pain.
PMID: 37530822 DOI: 10.1056/NEJMoa2209870